Resources

Welcome to our searchable resource and literature collection on safer supply and related topics.

Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.

 

To evaluate tapering of stable long-term opioid therapy (LTOT) and subsequent health care service use and chronic condition care.

Original research | 2023
Substitution/OAT, Policy/Regulatory, Transitions in care/treatment

This paper describes and compiles strategy selection and examines two hypotheses: 1) Overdose Education and Naloxone Distribution (OEND) selections will differ significantly between communities wit

Original research | 2023
Overdose, Rural/remote
Lit review | 2023
Evidence base

The Jackson severe injection drug use-related infection (SIRI) team was developed as an integrated infectious disease/SUD treatment intervention for patients hospitalized at a public safety-net hos

Original research | 2023
Hospitals, Injecting drugs, Barriers and enablers

This study aimed to understand stakeholder and provider perspectives on injectable opioid agonist treatment (iOAT) care and how it can be improved to better meet service users’ needs.

Original research | 2023
About prescribers, About PWUD, Substitution/OAT

People with OUD involved in the criminal legal system are a vulnerable population, yet little research has comprehensively examined post-release outcomes associated with receiving MOUDs in jail and

Lit review | 2023
Outcomes, About PWUD, Legal system/law enforcement, Substitution/OAT

This study aimed to longitudinally investigate incidence and predictors of first nonfatal overdose among women sex workers who use drugs.

Original research | 2023
Overdose, About PWUD, Legal system/law enforcement, Sex/Gender

We conducted a realist review of the literature to identify program theories that would explain successful and unsuccessful outcomes from residential treatment for SUD

Lit review | 2023
About PWUD, Transitions in care/treatment

We examined drug use practices, connectedness to other people who inject drugs, peer-to-peer injecting, and access to care among men who inject drugs in Melbourne, Australia.

Original research | 2023
2SLGBTQI+, Sex/Gender , Injecting drugs, About PWUD

We explored public support for safer supply programs in Saskatchewan and Alberta and identified predictors of support for this policy option.

Original research | 2023
Safer supply, Evidence base, Policy/Regulatory, Advocacy
Commentary | 2023
Harm reduction, Stigma, About PWUD

We explore individual-level, network-level, and community-level characteristics associated with MOUD uptake in young people who inject drugs and their support network members.

Original research | 2023
Youth, Injecting drugs, Substitution/OAT, Stigma, About PWUD

The objective of our study was to explore mental health clinician attitudes towards substance use and associations with clinical experience and education level

Original research | 2023
About prescribers, Stigma

In examining past policies, practices, and discourse that support heroin regulation and drug prohibition, the drivers of the current illegal drug overdose death epidemic in Canada are brought more

Original research | 2021
Policy/Regulatory, Legal system/law enforcement, Equity

We explored the likelihood of securing a new primary care provider (PCP) among people with varying histories of opioid use who had recently lost access to their PCP.

Original research | 2021
About PWUD, Stigma, Equity

This article examines how clinics’ take-home dosing policies have affected patients’ experiences of treatment and lives in general.

Original research | 2021
Carries/take-home doses, Stigma, Substitution/OAT, About PWUD, Policy/Regulatory, Barriers and enablers

This study evaluated how telemedicine as a modality for opioid agonist treatment compares to in-person care

Original research | 2021
Digital health
Livre | 2022
les drogues hallucinogènes/psychédéliques, la réduction des méfaits

To investigate excess costs of buprenorphine-naloxone due to unmerited market exclusivity (no legal patent or data protection) in Canada.

Original research | 2023
Policy/Regulatory, Barriers and enablers, Substitution/OAT

Refine Your Search

Keywords
Format
Region